Xeris Pharmaceuticals has teamed up with the American Diabetes Association (ADA) to raise awareness of the importance of ...

Number of calls for an ambulance or glucagon injections during the past month and past year should be considered as well as whether injuries may have been due to unidentified hypoglycemia.

This suggests that glucagon analogs could be a promising treatment option for patients experiencing postbariatric hypoglycemia. Additionally, digital health solutions are emerging as valuable ...

According to the ADA, nearly half of all people with type 1 diabetes suffer from at least one severe hypoglycemia event each year. For people with type 2 diabetes, that number is about 21%. Glucagon ...

Glucagon prescriptions for severe hypoglycemia rose in Medicaid beneficiaries with the introduction of newer products but likely met only a fraction of the high-risk population’s needs.